These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22593651)

  • 1. Meningioma: a clinicopathological evaluation.
    Samadi N; Ahmadi SA
    Malays J Med Sci; 2007 Jan; 14(1):46-52. PubMed ID: 22593651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of argyrophilic nucleolar organizer region staining in predicting the behavior of meningiomas.
    Ahmadi SA; Samadi N
    Ann Saudi Med; 2006; 26(1):38-42. PubMed ID: 16521873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgery for convexity meningiomas.
    Morokoff AP; Zauberman J; Black PM
    Neurosurgery; 2008 Sep; 63(3):427-33; discussion 433-4. PubMed ID: 18812953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary intracranial meningiomas after high-dose cranial irradiation: report of five cases and review of the literature.
    Strojan P; Popović M; Jereb B
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):65-73. PubMed ID: 10924973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign versus atypical meningiomas: risk factors predicting recurrence.
    Nowak A; Dziedzic T; Krych P; Czernicki T; Kunert P; Marchel A
    Neurol Neurochir Pol; 2015; 49(1):1-10. PubMed ID: 25666766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of p53 gene mutation in tumor aggressiveness of intracranial meningiomas.
    Cho H; Ha SY; Park SH; Park K; Chae YS
    J Korean Med Sci; 1999 Apr; 14(2):199-205. PubMed ID: 10331568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathodiagnostic parameters for meningioma grading.
    Moradi A; Semnani V; Djam H; Tajodini A; Zali AR; Ghaemi K; Nikzad N; Madani-Civi M
    J Clin Neurosci; 2008 Dec; 15(12):1370-5. PubMed ID: 18819804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical and malignant meningiomas: a clinicopathological review.
    Mahmood A; Caccamo DV; Tomecek FJ; Malik GM
    Neurosurgery; 1993 Dec; 33(6):955-63. PubMed ID: 8134008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Necrosis is a consistent factor to recurrence of meningiomas: should it be a stand-alone grading criterion for grade II meningioma?
    Góes P; Santos BFO; Suzuki FS; Salles D; Stávale JN; Cavalheiro S; de Paiva Neto MA
    J Neurooncol; 2018 Apr; 137(2):331-336. PubMed ID: 29270884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases.
    Palma L; Celli P; Franco C; Cervoni L; Cantore G
    J Neurosurg; 1997 May; 86(5):793-800. PubMed ID: 9126894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Atypical and malignant intracranial meningiomas].
    Gelabert-González M; Fernández-Villa JM; Iglesias-Pais M
    Rev Neurol; 2004 Feb 16-29; 38(4):304-10. PubMed ID: 14997451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases.
    Palma L; Celli P; Franco C; Cervoni L; Cantore G
    Neurosurg Focus; 1997 Apr; 2(4):e3. PubMed ID: 15096007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of the proliferative potential of meningiomas with MIB-1 monoclonal antibodies].
    Miyagami M; Shibuya T; Miyagi A; Tsubokawa T
    No To Shinkei; 1996 Jan; 48(1):39-43. PubMed ID: 8679317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical Outcome of Treating Grades II and III Meningiomas: A Report of 32 Cases.
    Violaris K; Katsarides V; Karakyriou M; Sakellariou P
    Neurosci J; 2013; 2013():706481. PubMed ID: 26317097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraspinal meningioma with malignant transformation and distant metastasis.
    Ito K; Imagama S; Ando K; Kobayashi K; Shido Y; Go Y; Arima H; Kanbara S; Hirose T; Matsuyama Y; Nishida Y; Ishiguro N
    Nagoya J Med Sci; 2017 Feb; 79(1):97-102. PubMed ID: 28303067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of HER2/neu in meningiomas: an immunohistochemistry and fluorescence in situ hybridization study].
    Wang CL; Mei JH; Wang SS; Xu S; Xu LL; Xiong YF
    Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):156-60. PubMed ID: 20450760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted MR imaging: diagnosing atypical or malignant meningiomas and detecting tumor dedifferentiation.
    Nagar VA; Ye JR; Ng WH; Chan YH; Hui F; Lee CK; Lim CC
    AJNR Am J Neuroradiol; 2008 Jun; 29(6):1147-52. PubMed ID: 18356472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma.
    Mason WP; Gentili F; Macdonald DR; Hariharan S; Cruz CR; Abrey LE
    J Neurosurg; 2002 Aug; 97(2):341-6. PubMed ID: 12186462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA topoisomerase II-alpha and cyclin A immunoexpression in meningiomas and its prognostic significance: an analysis of 263 cases.
    Korshunov A; Shishkina L; Golanov A
    Arch Pathol Lab Med; 2002 Sep; 126(9):1079-86. PubMed ID: 12204057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracranial meningioma with vertebral or intraspinal metastasis: report of 2 cases and review of the literature.
    Singh R; Ryan C; Chohan MO; Tisnado J; Hadjigeorgiou GF; Bilsky MH
    J Neurosurg Spine; 2016 Dec; 25(6):775-781. PubMed ID: 27420397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.